Clinical usefulness of the measurement of serum fructosamine in childhood diabetes mellitus
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Glycosylated hemoglobin (HbA1c) is often used as an indicator of glucose control. It usually reflects the average glucose levels over two to three months, and is correlated with the development of long-term diabetic complications. However, it can vary in cases of hemoglobinopathy or an altered red blood cell lifespan. The serum fructosamine levels reflect the mean glucose levels over two to three weeks. This study was designed to determine the clinical usefulness of the combined measurement of serum fructosamine and HbA1c in the management of childhood diabetes mellitus and the correlation between them. Methods: Clinical data on 74 Korean children and adolescents with diabetes mellitus who were under management at the Department of Pediatrics of Dankook University Hospital were evaluated. Their fructosamine and HbA1c levels were reviewed based on clinical information, and analyzed using IBM SPSS Statistics ver. 21. Results: Their HbA1c levels showed a strong correlation with their fructosamine levels (r=0.868, P<0.001). The fructosamine level was useful for the prompt evaluation of the recent therapeutic efficacy after the change in therapeutic modality. It was also profitable in determining the initial therapeutics and for the estimation of the onset of the disease, such as fulminant diabetes. Conclusion: The measurement of both fructosamine and HbA1c was useful in managing childhood diabetes mellitus, especially when there was discrepancy between the clinical information and the HbA1c level.
Abstract
Purpose: Glycosylated hemoglobin (HbA1c) is often used as an indicator of glucose control. It usually reflects the average glucose levels over two to three months, and is correlated with the development of long-term diabetic complications. However, it can vary in cases of hemoglobinopathy or an altered red blood cell lifespan. The serum fructosamine levels reflect the mean glucose levels over two to three weeks. This study was designed to determine the clinical usefulness of the combined measurement of serum fructosamine and HbA1c in the management of childhood diabetes mellitus and the correlation between them. Methods: Clinical data on 74 Korean children and adolescents with diabetes mellitus who were under management at the Department of Pediatrics of Dankook University Hospital were evaluated. Their fructosamine and HbA1c levels were reviewed based on clinical information, and analyzed using IBM SPSS Statistics ver. 21. Results: Their HbA1c levels showed a strong correlation with their fructosamine levels (r=0.868, P<0.001). The fructosamine level was useful for the prompt evaluation of the recent therapeutic efficacy after the change in therapeutic modality. It was also profitable in determining the initial therapeutics and for the estimation of the onset of the disease, such as fulminant diabetes. Conclusion: The measurement of both fructosamine and HbA1c was useful in managing childhood diabetes mellitus, especially when there was discrepancy between the clinical information and the HbA1c level.
참고문헌 (40)
- Alemzadeh R, "Nelson textbook of pediatrics", pp.1968~1997 (2011), Elsevier Saunders
- "Haemoglobin A1 and diabetes; a reappraisal", Br Med J, 281, pp.1304~1305 (1980)
- Graf RJ, "Glycosylated hemoglobin in normal subjects and subjects with maturity-onset diabetes. Evidence for a saturable system in man", Diabetes, 27, pp.834~839 (1978)
- Boden G, "Monitoring metabolic control in diabetic outpatients with glycosylated hemoglobin", Ann Intern Med, 92, pp.357~360 (1980)
- Kennedy AL, "Glycosylated serum protein and hemoglobin A1 levels to measure control of glycemia", Ann Intern Med, 95, pp.56~58 (1981)
- Baker JR, "Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus", Br Med J (Clin Res Ed), 287, pp.863~867 (1983)
- Chen HS, "Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4", Am J Kidney Dis, 55, pp.867~874 (2010)
- Shafi T, "Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients", Diabetes Care, 36, pp.1522~1533 (2013)
- Chon S, "Evaluation of glycemic variability in wellcontrolled type 2 diabetes mellitus", Diabetes Technol Ther, 15, pp.455~460 (2013)
- Nathan DM, "Translating the A1C assay into estimated average glucose values", Diabetes Care, 31, pp.1473~1478 (2008)
- Desrocher M, "Neurocognitive correlates of type 1 diabetes mellitus in childhood", Child Neuropsychol, 10, pp.36~52 (2004)
- Daneman D, "Severe hypoglycemia in children with insulin-dependent diabetes mellitus: frequency and predisposing factors", J Pediatr, 115(5 Pt 1), pp.681~685 (1989)
- Davis EA, "Impact of improved glycaemic control on rates of hypoglycaemia in insulin dependent diabetes mellitus", Arch Dis Child, 78, pp.111~115 (1998)
- Cohen RM, "Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy", Diabetes Care, 26, pp.163~167 (2003)
- "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus", N Engl J Med, 329, pp.977~986 (1993), The Diabetes Control and Complications Trial Research Group
- Ohkubo Y, "Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study", Diabetes Res Clin Pract, 28, pp.103~117 (1995)
- "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)", Lancet, 352, pp.837~853 (1998), UK Prospective Diabetes Study (UKPDS) Group
- Sacks DB., "A1C versus glucose testing: a comparison", Diabetes Care, 34, pp.518~523 (2011)
- Sabanayagam C, "Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?", Diabetologia, 52, pp.1279~1289 (2009)
- Wright LA, "The challenge of the use of glycemic biomarkers in diabetes: reflecting on hemoglobin A1C, 1,5-Anhydroglucitol, and the glycated proteins fructosamine and glycated albumin", Diabetes Spectrum, 25, pp.141~148 (2012)
- Panzer S, "Glycosylated hemoglobins (GHb): an index of red cell survival", Blood, 59, pp.1348~1350 (1982)
- Shapira Y, "Hemolysis associated with prosthetic heart valves: a review", Cardiol Rev, 17, pp.121~124 (2009)
- Jain N, "Hemoglobin Raleigh results in factitiously low hemoglobin A1c when evaluated via immunoassay analyzer", J Diabetes Complications, 25, pp.14~18 (2011)
- Bry L, "Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin", Clin Chem, 47, pp.153~163 (2001)
- Eschbach JW., "The anemia of chronic renal failure:pathophysiology and the effects of recombinant erythropoietin", Kidney Int, 35, pp.134~148 (1989)
- Ly J, "Red blood cell survival in chronic renal failure", Am J Kidney Dis, 44, pp.715~719 (2004)
- Derr R, "Is HbA(1c)affected by glycemic instability?", Diabetes Care, 26, pp.2728~2733 (2003)
- Ceriello A., "Postprandial hyperglycemia and diabetes complications: is it time to treat?", Diabetes, 54, pp.1~7 (2005)
- Monnier L, "Activation of oxidative stress by acute glucose f luc tuat ions compared with sus t ained chroni c hyperglycemia in patients with type 2 diabetes", JAMA, 295, pp.1681~1687 (2006)
- Juraschek SP, "Alternative markers of hyperglycemia and risk of diabetes", Diabetes Care, 35, pp.2265~2270 (2012)
- Rondeau P, "The glycation of albumin: structural and functional impacts", Biochimie, 93, pp.645~658 (2011)
- Buse JB, "Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker", Diabetes Technol Ther, 5, pp.355~363 (2003)
- Rubinow KB, "Reexamining metrics for glucose control", JAMA, 305, pp.1132~1133 (2011)
- Freedman BI, "Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis", Perit Dial Int, 30, pp.72~79 (2010)
- Peacock TP, "Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis", Kidney Int, 73, pp.1062~1068 (2008)
- Inaba M, "Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection", J Am Soc Nephrol, 18, pp.896~903 (2007)
- True MW., "Circulating biomarkers of glycemia in diabetes management and implications for personalized medicine", J Diabetes Sci Technol, 3, pp.743~747 (2009)
- Baker JR, "Serum fructosamine concentrations in patients with type II (non-insulindependent)diabetes mellitus during changes in management", Br Med J (Clin Res Ed), 288, pp.1484~1486 (1984)
- Tattersall R, "A critical evaluation of methods of monitoring diabetic control", Diabetes Care, 3, pp.150~154 (1980)
- Hanafusa T, "Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners", Nat Clin Pract Endocrinol Metab, 3, pp.36~45 (2007)